Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Does LSD induce genuine synesthesia — or something different?

by Eric W. Dolan
May 17, 2016
in Psychopharmacology
Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

A new placebo-controlled study has confirmed that the psychedelic drug LSD can induce synesthesia-like experiences. But the preliminary research, published in the journal Neuropsychologia, raises questions about whether LSD produces “genuine” synesthesia.

Synesthesia occurs when a person experiences an overlap in their senses. A person experiencing synesthesia might be able to taste colors or see sounds.

“Genuine” synesthesia occurs when a specific perception (called the “inducer”) automatically provokes another specific perception (called the “concurrent”). In genuine synesthetes, this pairing between the inducer and the concurrent remains fairly consistent over time. People with grapheme-color synesthesia, for example, might see the color green whenever they see the number 6.

There have been anecdotal reports about LSD causing synesthesia ever since the psychedelic drug was first discovered by Albert Hofmann in the 1930s. Research from the 1950s and 1960s also suggested that LSD could induce synesthesia. But these initial studies had a number of methodological problems, causing researchers to remain uncertain about LSD’s potential to induce genuine synesthesia.

To start to reduce this uncertainty, a group of scientists from the United Kingdom, led by Devin B. Terhune of Goldsmiths, University of London (previously University of Oxford), recruited nine men and one woman for study on LSD and synesthesia.

The ten participants were all deemed to be physically and psychologically healthy, and had prior experience with psychedelic drugs. During an initial testing session, they were injected with a saline solution, which acted as a placebo, before completing psychological tests to measure synesthesia-like experiences. After five to seven days, the participants were invited back for a second session. But this time, they were injected with 40-80 micrograms of LSD.

Terhune and his colleagues employed two verified tests of synesthesia — a grapheme-color association test and a sound-color association test. But the researchers found that the effects of LSD did not meet two of the accepted criteria for genuine synesthesia — consistency and specificity. The specific graphemes and sounds did not produce specific color experiences, and the associations between graphemes, sounds and colors were not more consistent under LSD than placebo.

The type of synesthesia produced by LSD could be “qualitatively different” from genuine synesthesia, the researchers said.

However, it is also possible that the effects of LSD failed to meet the accepted criteria for genuine synesthesia because the study was statistically underpowered due to the small number of participants.

“The fact that we didn’t observe increased stimulus-color consistency under LSD is an important issue because consistency is the most widely-used criterion for congenital synesthesia. I tend to believe this data is reliable as it was in the opposite direction of what was predicted if LSD was producing genuine synesthesia,” Terhune explained to PsyPost via email. “The inducer specificity data is harder to interpret because it was in the predicted direction but still clearly non-significant. This places it more in ambiguous territory.”

LSD and other psychedelic drugs present a problem for synesthesia researchers. Genuine synesthesia is considered a reliable and consistent phenomenon. One specific perception consistently induces another specific perception. The tests designed to measure synesthesia reflect this consistency. But the synesthesia-like experiences produced by LSD appear to be inconsistent and transient.

“This is a difficult issue because standard criteria for synesthesia have served the field well and synaesthetes almost universally meet these criteria. Alternatively, it may be that current definitions of what qualifies as synesthesia are overly narrow. To be honest, we’re really not sure at this point which way to go on this,” Terhune told PsyPost.

The criteria for synesthesia may need to be updated, or the synesthesia-like experiences produced by LSD may need to be treated as a unique phenomenon.

“If they are qualitatively different, then yes, we’ll need to develop new ways to study the multisensory effects reported by people on LSD. Studying drug-induced synesthesia-like experiences may prove very challenging if the experiences are completely transient and not very reliable. It may be conceptually similar to studying hallucinations, which are difficult to reliably induce in a laboratory setting,” Terhune explained to PsyPost.

TweetSendScanShareSendPin1ShareShareShareShareShare

RELATED

A surprising body part might provide key insights into schizophrenia risk
Addiction

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

July 11, 2025

After heroin exposure and abstinence, mice showed reduced prefrontal brain activity during social interaction but heightened responses to drug-related cues, suggesting heroin disrupts normal brain function in ways that may contribute to social withdrawal and relapse risk.

Read moreDetails
Loss of empathy in frontotemporal dementia traced to weakened brain signals
ADHD

Adults treated with psychostimulants for ADHD show increased brain surface complexity, study finds

July 10, 2025

Researchers have discovered that long-term psychostimulant use in adults with ADHD is associated with increased brain surface complexity, yet these anatomical differences appear unrelated to clinical outcomes, according to a study using high-resolution MRI data from UCLA.

Read moreDetails
Little-known psychedelic found to have a fascinating effect on cognitive flexibility after just a single dose
Psychedelic Drugs

Fascinating new advances in psychedelic science reveal how they may heal the mind

July 9, 2025

A series of recent studies has begun to map the specific neural, cognitive, and emotional processes that psychedelics influence—often in ways that challenge long-held assumptions

Read moreDetails
Ketamine repairs reward circuitry to reverse stress-induced anhedonia
Depression

Ketamine repairs reward circuitry to reverse stress-induced anhedonia

July 9, 2025

New research shows a single low, non-anesthetic dose of ketamine revived pleasure seeking in chronically stressed mice by restoring weakened excitatory synapses onto nucleus accumbens dopamine D1 neurons, pinpointing a circuit mechanism for the drug’s rapid antidepressant effect.

Read moreDetails
Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

New research identifies four distinct health pathways linked to Alzheimer’s disease

A surprising body part might provide key insights into schizophrenia risk

Religious belief linked to lower anxiety and better sleep in Israeli Druze study

A common vegetable may counteract brain changes linked to obesity

Massive psychology study reveals disturbing truths about Machiavellian leaders

Dementia: Your lifetime risk may be far greater than previously thought

Psychopathic tendencies may be associated with specific hormonal patterns

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy